EcoDrugPlus

V-Akt Murine Thymoma Viral Oncogene Homolog 3a

Ensembl ID : ENSLOCG00000015396
Gene Symbol: AKT3A
1 Cross references
203 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSLOCG00000016005
Gene Symbol: VEGFA
3 Cross references
253 Possible Orthologues:

Vasopressin V2 Receptor-Like

Ensembl ID : ENSLOCG00000000052
Gene Symbol: LOC102698801
2 Cross references
230 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSLOCG00000005194
Gene Symbol: VDR
3 Cross references
459 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSLOCG00000000048
Gene Symbol: LOC102696686
3 Cross references
190 Possible Orthologues:

Voltage-Dependent P/q-Type Calcium Channel Subunit Alpha-1a-Like

Ensembl ID : ENSLOCG00000017205
Gene Symbol: LOC107076501
2 Cross references
192 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSLOCG00000015803
Gene Symbol: XDH
1 Cross references
211 Possible Orthologues:

Ensembl ID : ENSLOCG00000001863
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSLOCG00000000249
Gene Symbol: -
Cross references: -
278 Possible Orthologues:

Ensembl ID : ENSLOCG00000011638
Gene Symbol: RPL10A
2 Cross references
299 Possible Orthologues:

Ensembl ID : ENSLOCG00000014762
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSLOCG00000001762
Gene Symbol: -
Cross references: -
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).